Portal Biotech
Latest round
- Series A
Last raised
- Jun 2025
Total raised
- $35M
Investors
- 10
About Portal Biotech
Founded in 2021 and headquartered in London, UK, Portal Biotech Limited focuses on single-molecule proteomics.Portal Biotech specializes in single-molecule proteomics, offering innovative bench-top instruments for protein characterization. Utilizing nanopore technology, their platform provides high sensitivity analysis for a range of proteins and metabolites. Their machine learning algorithms interpret electrical signatures produced by molecules, enabling precise insights into protein identity and modifications.Portal Biotech generates revenue through protein characterization services and the sale of proprietary bench-top instruments, primarily targeting academic and commercial laboratories. Their B2B model allows clients to access real-time protein sample analyses and tailored workflows, with pricing based on service complexity and duration. The company aims to introduce new products and expand into emerging markets, although specific release dates and targeted regions have yet to be disclosed.
Who invested in Portal Biotech
10 investors across 1 round
See all investors in Portal Biotech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jun 20, 2025
Amount
$35M
Investors
Questions about Portal Biotech
Who invested in Portal Biotech?
Portal Biotech has 10 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Portal Biotech raised?
Portal Biotech has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Portal Biotech last raise money?
Portal Biotech's most recent round on record is a Series A, in Jun 2025.
What does Portal Biotech do?
Founded in 2021 and headquartered in London, UK, Portal Biotech Limited focuses on single-molecule proteomics.
Where is Portal Biotech headquartered?
Portal Biotech is headquartered in London, UK.
Which VCs invest in companies like Portal Biotech?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Portal Biotech's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Portal Biotech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.